Product Name: Human C1s Antibody (Sutimlimab, Research Use)
Catalog Number: NBR-0113
Target Name: C1s
Trade Name: Sutimlimab
Antibody Drug Description: Sutimlimab, sold under the brand name Enjaymo, is a monoclonal antibody that is used to treat adults with cold agglutinin disease (CAD). It is given by intravenous infusion.Sutimlimab prevents complement-enhanced activation of autoimmune human B cells in vitro. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: C1s
Synonyms: 
Target Description: C1S (Complement C1s) is a Protein Coding gene. Diseases associated with C1S include Ehlers-Danlos Syndrome, Periodontal Type, 2 and Complement Component C1s Deficiency. Among its related pathways are Complement cascade and Initial triggering of complement. Gene Ontology (GO) annotations related to this gene include calcium ion binding and serine-type endopeptidase activity. An important paralog of this gene is C1R.
Ensembl: ENSG00000182326
Uniprot: P09871